Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor Agonist Era
JAMA Surgery · 01.05.2026 · 161 (5) · 546
DOI: 10.1001/jamasurg.2026.0049 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Surgery, erschienen am 01.05.2026. Verfasst von Stefanie C Rohde und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of General and Gastrointestinal Surgery, Department of Surgery, Ohio State University Wexner Medical Center, Columbus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This cross-sectional analysis examines trends through 2025 in the use of metabolic and bariatric surgery during a period of increasing use of glucagon-like peptide-1 (GLP-1) receptor agonists.
Autor:innen und Institutionen
- Division of General and Gastrointestinal Surgery, Department of Surgery, Ohio State University Wexner Medical Center, Columbus.
- Division of Minimally Invasive Surgery, Department of Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
- Division of Biostatistics and Population Health, Department of Biomedical Informatics, College of Medicine, Ohio State University Wexner Medical Center, Columbus.
- Division of Medical Oncology, Department of Internal Medicine, College of Medicine, Ohio State University Wexner Medical Center, Columbus.
Zitieren
APA
Rohde, S. C., Chao, G. F., Abdel-Rasoul, M., Elsaid, M. I., & Sweigert, P. J. (2026). Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor Agonist Era. JAMA Surgery, 161(5), 546. https://doi.org/10.1001/jamasurg.2026.0049
Vancouver
Rohde SC, Chao GF, Abdel-Rasoul M, Elsaid MI, Sweigert PJ. Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor Agonist Era. JAMA Surgery. 2026;161(5):546. doi:10.1001/jamasurg.2026.0049
BibTeX
@article{Rohde2026,
author = {Rohde, Stefanie C and Chao, Grace F and Abdel-Rasoul, Mahmoud and Elsaid, Mohamed I and Sweigert, Patrick J},
title = {Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor Agonist Era},
journal = {JAMA Surgery},
year = {2026},
volume = {161},
number = {5},
pages = {546},
doi = {10.1001/jamasurg.2026.0049}
}
EUVIMED